China's medical device market has grown to $13 billion, the second largest in Asia after Japan. The number of foreign medical device manufacturers registering their products in China has grown exponentially. View our webcast to learn about the new regulations in China.... Read More
Singapore, a small island nation in the South China Sea with a population of 5.5 million, has recently become a hot spot for sophisticated pharmaceutical research and manufacturing. In 2013, the country had an average purchasing power parity (PPP) per-capita GDP of... Read More
The ten nations that make up the Association of Southeast Asian Nations (ASEAN) -- Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand and Vietnam -- together have a population of over 610 million, almost twice the population of the U.S.... Read More
2013年12月17日，中国国家食品药品监督管理总局 （CFDA）发布简化版医疗器械重新注册流程，该流程于2014年1月1日开始生效。更新后的流程将减小生产商方面的文书负担，加快认证更新的通过时间，从而让核准机关可更专注于产品上市后的监管和新产品认证。这一举措是食药监总局加强和简化医疗器械管理的系列步骤中的最新举动。 Read More
Over the course of 2013, India's healthcare sector took several steps to strengthen drug and clinical trial regulations, re-established the elected Medical Council of India, and made progress in the Health Ministry's work to develop alternative and cheaper technologies like an indigenous... Read More
Japan is the second largest medical device market in the world. Getting through the registration process and selling your product on the market is not an easy task. This webcast will focus on key steps including PMDA consultation sessions, how to maximize... Read More
Indonesia, a country of more than 6,000 inhabited islands, has a population of over 250 million people -- the fourth most populous country in the world. Indonesia's GDP grew slightly less than 6% in 2013, and is forecast to grow between 5-6%... Read More
The Philippines, a Southeast Asian country made up of more than 7,000 islands, has a population of over 100 million people -- making it the 12th most populous country. 2013 Philippine GDP growth was among the fastest in Asia, at almost 7%.... Read More
印度立法委员再次延缓关于一项已提交议案的讨论，此议案将在印度史上首次对于所有在印度境内生产或销售的医疗产品进行全面性的法规约束。2013药品和化妆品法案（修订案）要求为医疗器械建立单独的类别，并且创建医疗器械专家咨询委员会，为执法者提供咨询建议。 Read More
Indian legislators again delayed the discussion of a proposed bill that would, for the first time in the country's history, require comprehensive regulation of all medical devices manufactured in or sold in India. The Drugs and Cosmetics (Amendment) Bill 2013 calls for... Read More